Back to results
US 2012/0252805 A1Published application
Novel compounds
AssigneeGlaxoSmithKline Intellectual Property Limited
InventorsDeborah Chen, Kiew Ching Lee, Lamont Roscoe Terrel
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel NADPH oxidase II inhibitors and their use in the treatment of diseases mediated by the NADPH oxidase II enzyme.
Claims15
1-19. (canceled)
A compound of Formula (I) or a pharmaceutically acceptable salt thereof
- wherein:
- R1 is selected from the group consisting of:
- H, halo, CN, (CH2)nNRaRa, C(O)NRaRa, C(O)ORb, NRbC(O)Rb, (CH2)mORb,
- C1-C6 alkyl optionally substituted with heterocycloalkyl,
- heterocycloalkyl,
- C1-C6 alkynyl optionally substituted with OH, C1-C3 alkoxy, NRaRa or heterocycloalkyl,
- (CH2)nRc wherein Rc is optionally substituted with one or more substituents selected from the group consisting of C1-C3 alkoxy, C1-C3 alkyl, NRaRa and halo, and
- (CH2)nRd wherein Rd is optionally substituted with one or more substituents selected from the group consisting of C1-C3 alkoxy, C1-C3 alkyl, NRaRa and halo;
- R2 is selected from the group consisting of:
- H, halo, CN, C(O)NRaRa,
- C1-C6 alkyl,
- heterocycloalkyl,
- (CH2)nRc wherein Rc is optionally substituted with one or more substituents selected from the group consisting of C1-C3 alkoxy, (CH2)nNRaC(O)ORa, (CH2)nNRaRa, halo, C1-C4 alkyl optionally substituted with one to three F, and heterocycloalkyl optionally substituted with C(O)ORb, and
- (CH2)nRd wherein Rd is optionally substituted with one or more substituents selected from the group consisting of C1-C4 alkyl, C1-C3 alkoxy, halo, heterocycloalkyl and (CH2)nNRaRa;
- R3 is selected from the group consisting of:
- C1-C6 alkyl optionally substituted with Rc wherein Rc is optionally substituted with halo,
- heterocycloalkyl optionally substituted with one or more substituents selected from the group consisting of halo and C(O)ORb wherein Rb is optionally substituted with phenyl,
- cycloalkyl,
- Rc optionally substituted with one or more substituents selected from the group consisting of C1-C3 alkoxy, NRaRa, NO2, halo, and C1-C4 alkyl optionally substituted with one to three F, and
- Rd optionally substituted with one or more substituents selected from the group consisting of C1-C4 alkyl, C1-C3 alkoxy, halo and phenyl;
- R4 is H, C1-C6 alkyl, C1-C3 alkoxy, halo, CN or OH;
- each Ra is H or C1-C6 alkyl or both Ra groups, independently in each instance, taken together with the nitrogen atom to which they are attached form a 5 to 7 membered heterocycloalkyl ring;
- each Rb is H or C1-C6 alkyl;
- each Rc is phenyl;
- each Rd is heteroaryl;
- each m is 1 or 2;
- and
- each n is 0, 1, 2 or 3.
25 more elements
Dependencies are inferred from the claim text.